
'It's completely unfair:' Moms in western Quebec fear arsenic emissions from Horne Smelter
A resident of Rouyn-Noranda, Que., home of the Horne Smelter which has been in operation since 1927, the mom of three says the solution is not as simple as moving away.
"It's very complex," said Turcotte, standing outside Quebec's National Assembly, taking part in a protest on Thursday.
"We're attached to the area, we love our community… it's extremely difficult to know you have to deal with this risk."
For years, residents like Turcotte have been raising awareness about the need to lower arsenic emissions in her hometown.
While there have been several studies on the effects of Canada's only copper smelter, a 2022 study by Quebec's Institute of Public Health (INSPQ) confirmed higher rates of cancer and pulmonary diseases are directly linked to high arsenic and cadmium emissions in Rouyn-Noranda due to the Horne Smelter.
The co-spokesperson for Mères au front de Rouyn-Noranda, Turcotte is among the locals demanding that those living in the town located in western Quebec face the same level of risk as other Quebecers.
Kids particularly vulnerable to toxins
In the early 1900s, prospector Edmund Henry Horne discovered copper and gold in the area, which led to mining and the development of the town of Noranda — which later merged with neighbouring Rouyn.
The smelter was built in 1926, long before environmental norms were established. It is owned now by Glencore Canada, whose Swiss parent company produces and markets a range of metals and minerals worldwide.
In 2024, the smelter announced it was making progress toward reducing arsenic emissions, saying it was down nearly 40 per cent from the year before.
The smelter said about 99 per cent of the urban area of Rouyn-Noranda had emissions of 15 nanograms of arsenic per cubic metre of air or below. Meanwhile, Quebec's provincial norm for arsenic emissions is an annual average of three nanograms per cubic metre.
In 2021, the smelter was permitted to emit a maximum of 100 nanograms per cubic metre of arsenic into the air, or 33 times the Quebec standard.
Arsenic is associated with things like skin, lung, liver and bladder cancer, says Dr. Koren Mann, professor and chair of pharmacology and therapeutics at McGill University.
Having studied the effects of arsenic, she says it's also associated with cardiovascular diseases, immune changes and diabetes.
"We don't know how long it takes to develop a disease," said Mann. "We don't know if you're exposed as a child and you remove them from the arsenic, does that decrease the risk later on?"
She says kids are particularly vulnerable as their brains, bones and immune systems are growing.
"These tend to be really vulnerable stages for environmental exposures and environmental toxins," said Mann.
'My children are no less important,' says resident
On Thursday, dozens of protesters stood in solidarity in Quebec City — some smearing black paint across their bodies to symbolize the effects of the chemicals on residents.
"It's the only place where this [provincial] standard isn't forced to be applied. So it doesn't make sense," said Isabelle Fortin-Rondeau with Mères au front de Rouyn-Noranda.
"My children are no less important than children in Quebec City or Montreal. My children's health is no less important than that of the children of elected officials."
Fortin-Rondeau says she's not sure she made the right decision moving back to Rouyn-Noranda to raise her family.
Having left her hometown for years, she said when she returned home, she wasn't aware of the "extent of the contamination."
"I've been exposing my children for an average of 15 years to all these contaminants, and potentially to developing cancer," said Fortin-Rondeau. "I say to myself, 'well, my God, if I knew this, I could have made different choices.'"
New biomonitoring program for employees
On Thursday, at the same time as the protest in Quebec City, the smelter held a news conference in Rouyn-Noranda to announce an arsenic biomonitoring program to evaluate the exposure of environmental contaminants among its employees, their social circles and families.
Measuring concentrations of substances found in participants' urine and fingernails, for example, the company says participation in the study will be voluntary.
To participate, employees and their families must contact the teams at Intrinsik — a science-based consulting firm.
As part of the announcement, the smelter's general manager, Vincent Plante, said 2018 and 2019 biomonitoring studies left questions unanswered and that the company is looking for more information on the "real internal exposure" of arsenic.
The research that has been done so far has provided a very select picture, says Mann.
"We don't have even a good handle on what the long-term consequences are," she said.
"Residents in Rouyn-Noranda have a higher level of lung cancer than the average Quebec population and yet have lower rates of tobacco smoking … is it the arsenic?"
As a resident of the city, Turcotte says she feels the smelter's announcement is part of a strategy to attempt to "dilute what we already know."
"We know the risks associated with the contaminants we're exposed to and they're sufficient for the government to enforce standards," she said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Toronto Sun
8 hours ago
- Toronto Sun
First case of Rocky Mountain spotted fever discovered in Quebec
Patient in Eastern Townships recovering after antibiotics Published Aug 19, 2025 • Last updated 2 hours ago • 3 minute read Quebec has detected its first human case of Rocky Mountain spotted fever Source: Institut national de santé publique du Québec (INSPQ) In the latest sign of climate change impacting human health in Quebec, authorities on Monday confirmed the first case in the province of Rocky Mountain spotted fever — a potentially life-threatening tick-borne illness more commonly found in southern regions of the United States but that is now making its way into Canada amid rising temperatures. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account 'We are aware of the situation and are monitoring it closely to obtain more information about the presence of this disease in Quebec,' a Health Ministry spokesperson told The Gazette. 'In the meantime, the best way to protect yourself against ticks is to avoid being bitten by taking preventive measures' like wearing pants and long-sleeves when venturing outdoors and using mosquito repellant. Dr. Alex Carignan, a microbiologist and infectious diseases specialist at the CIUSSS de l'Estrie, took to social media to inform the public about the case. 'Recently, we identified a case of Rocky Mountain spotted fever (RMSF) infection in the Eastern Townships,' Carignan said in a post on X. 'This is the first case of transmission in Quebec. Fortunately, the patient responded well to doxycycline (antibiotic) treatment. This infection causes high fevers, a distinctive rash, and can lead to death if not properly managed. 'We knew that this bacterium (Rickettsia rickettsiae) would arrive in the coming years, but unfortunately it showed up a bit earlier than expected,' Carignan added. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. Infections transmises par les tiques: une nouvelle venue au Québec. Récemment, nous avons identifé un cas d'infection à la fièvre pourprée des montagnes rocheuses ("rocky mountain spotted fever") acquis en Estrie. Il s'agit du premier cas de transmission au Québec.… — Alex Carignan (@carignan_alex) August 18, 2025 Dr. Isaac Bogoch, an infectious diseases physician and scientist at the University Health Network in Toronto, noted that RMSF was 'recently also seen in dogs in Long Point, Ont.' on the north shore of Lake Erie. 'RMSF is an uncommon but very serious tick-born infection,' Bogoch added on X. RMSF is not to be confused with Lyme disease, which is an infection that can also be contracted from tick bites. In contrast with RMSF's local rarity, Lyme disease has now become endemic on the Island of Montreal. Yet only a decade ago Lyme disease was considered somewhat of a rare occurrence in Montreal. The outlook for RMSF is good if treated early. Still, the death rate from RMSF hovers between 5 and 10 per cent in the U..S, even with treatment, according to the Cleveland Clinic. This advertisement has not loaded yet, but your article continues below. A 2019 study by Quebec and Manitoba researchers warned that the risk of tick-borne diseases in Canada was expected to rise in the coming years because of climate change. 'Climate warming and other environmental changes have contributed to the expansion of the range of several tick species into higher latitudes in North America,' the authors concluded in the study. 'As temperatures increase in Canada, the environment becomes more suitable for ticks and the season suitable for tick activity lengthens, so tick-borne diseases are likely to become more common in Canada. In addition to Lyme disease, four other tick-borne diseases (TBDs) have started to emerge and are likely to increase: Anaplasmosis; Babesiosis; Powassan virus; and Borrelia miyamotoi disease. Increased temperature increases the survival and activity period of ticks, increases the range of both reservoir and tick hosts (e.g. mice and deer) and increases the duration of the season when people may be exposed to ticks.' This advertisement has not loaded yet, but your article continues below. And now authorities can add Rocky Mountain spotted fever to that list. Climate change is not just responsible for the spread of TBDs into Canada harming human health. Lingering smoke from wildfires in northern Quebec and the prairie provinces — which are becoming more common because of human-induced climate change creating ever-hotter and drier weather conditions — is resulting is more respiratory and other illnesses. In July, the Association québécoise des médecins pour l'environnement (AQME) sounded the alarm about the deleterious long-term effects on Quebecers' health due to their chronic exposure to polluted air. And during the heat wave last week, Montreal public-health officials confirmed three heat-related deaths and two cases of heatstroke. On Aug. 11, Montreal set a new temperature record of 35.1 C at Trudeau airport. Toronto Blue Jays Sunshine Girls Canada Sunshine Girls Money News

CTV News
11-08-2025
- CTV News
Animal sedative increasingly found in illegal drugs in Quebec
Prescription pills containing oxycodone and acetaminophen are shown in this June 20, 2012 photo. (Graeme Roy / The Canadian Press) An emerging substance is increasingly being detected in illicit drugs in Quebec. Called medetomidine, it's primarily a sedative and analgesic used by veterinarians. Medetomidine is not approved for use in humans, but on the illegal drug market, the new additive is often mixed with opioids, mainly fentanyl. It is also found in other substances with sedative effects or synthetic benzodiazepines. Medetomidine is frequently detected in drug samples seized and analyzed in the United States and Canada, according to a recent report by Quebec's public health institute (INSPQ). In Canada, medetomidine was first detected in 2022 in a powder sample in Ontario. The substance became more commonly detected in the country in 2024. According to data from Health Canada's Drug Analysis Service, 925 samples analyzed between January and September 2024 contained medetomidine, most of which were drugs seized in Ontario, accounting for 85 per cent of Canadian detections. In Quebec, it was first detected in April 2023. Since then, medetomidine has been found about 20 times, representing less than two per cent of all detections of the substance in Canada. The main risk of consuming medetomidine is its powerful sedative effect, especially when taken with other substances that work as depressants on the central nervous system. 'This situation is particularly concerning given that people may consume this substance without knowing it,' said the INSPQ. Other side effects include dizziness, sedation, slow heart rate, hypothermia, low blood pressure, slow breathing and respiratory depression. Medetomidine can be even more dangerous when consumed with other sedative substances, as it can amplify the effects of drowsiness, low blood pressure, slow heart rate and slow breathing. This report by The Canadian Press was first published in French on Aug. 11, 2025. The Canadian Press health coverage is supported by a partnership with the Canadian Medical Association. The Canadian Press is solely responsible for this journalistic content.

06-08-2025
Danny McCarthy remis en liberté sous conditions
(Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported on Wednesday, citing people familiar with the matter. Shares of Avidity rose 23% to $47.1. It has a market value of $4.6 billion, according to LSEG data. Novartis has been evaluating a bid for Avidity and expressed interest in an acquisition in recent weeks, the report said, in a move aimed at boosting the drugmaker's pipeline of medicines targeting rare genetic disorders. The discussions were at an early stage, the report said, adding that the sources had cautioned that another suitor could emerge or talks could collapse. Avidity, which has been developing treatments for rare muscle disorders, is working with advisers to assess options, the people added. Novartis and Avidity declined to comment when contacted by Reuters. Del-zota, Avidity's lead drug, is in early to mid-stage development as a potential treatment for a rare form of Duchenne muscular dystrophy. The company is also working on two other drugs for serious muscle diseases. Novartis has been actively striking deals in 2025 as it looks to bolster its drug pipeline and drive future growth. In February, Novartis agreed to acquire Anthos Therapeutics for $3.1 billion to enhance its cardiovascular portfolio. The company also struck a deal in April valued at up to $1.7 billion to acquire Regulus Therapeutics, gaining access to an experimental treatment for a serious kidney disease. Additionally, last month Novartis partnered with Matchpoint Therapeutics in a deal worth up to $1 billion to develop oral medicines targeting several inflammatory conditions. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Arun Koyyur and Shailesh Kuber)